NXT-ID Readies MobileBio Biometrics Solutions Suite for New
NXT-ID Readies MobileBio Biometrics Solutions Suite for New Show
http://www.mobilecommerceinsider.com/topics/m...te-new.htm
By Steve Anderson
Contributing TMCnet Writer
The rise of mobile commerce has brought with it a wide array of new opportunities across several different sectors, including crime. Where there are a lot of people with a lot of money, so too will there be not only people out to provide said people with goods and services in exchange for some of that money, but also those just out to take the money outright. This has brought in an increased need for security in mobile commerce, and NXT-ID may have just the solution in its MobileBio line of biometric security mechanisms.
Perhaps the most well-known part of the NXT-ID MobileBio line is the Wocket smart wallet, a device designed to essentially replace most every card in a user's wallet—with the possible exception of the driver's license—all without the need to have a smartphone around to serve as infrastructure. The Wocket will work anywhere where a credit card can be taken—there seems to be no need for new hardware at the point of sale—and will work on the strength of a biometric “stamp of approval,” as it's being called.
Additionally, there's the MobileBio biocloud, which uses cloud systems to establish a kind of biometric database easily accessed by points of entry, so that said points can easily refer to a central location for biometric information. The MobileBio facematch system offers a choice of 2D, 3D, or pseudo-3D face matching technology for mobile devices and even desktop computers, while the MobileBio voicematch system allows the user's voice to serve as a password by matching up the unique voiceprint that each user has.
But as impressive as the MobileBio line is by itself, it won't be the only thing that NXT-ID has in mind to show off. It's also bringing out a complete 3D facial recognition system, yielded from the efforts of NXT-ID's wholly-owned subsidiary, 3D-ID LLC. The company has fully 22 licensed patents to its credit so far, and has a host of applications from regular access control to uses across a spectrum of law enforcement operations from prisons to issues of Homeland Security. NXT-ID will be taking its array of solutions to the Defense and Security Conference, running March 11 at the New York Hilton Midtown.
What NXT-ID seems to have in this mix is not only a complete identification package but an immediately-available place to put this identification package to work. It's one thing to have a great package of solutions, but it's even better when a separate solution can be put to work, tailor-made, to put that package of solutions immediately to work. It's almost like guaranteeing a market of sorts, particularly if the place where the solutions can help is itself popular. It's almost like if Goodyear made a car that ran best with Goodyear tires. While the tires individually might have a market, going with the Goodyear car helps provide a whole other place to use these tires. Plus the profit from the car line goes into the wider business, which can be used for research and development to bring out further improvement and make the line more likely to turn a profit.
NXT-ID's systems should prove a welcome entrant into the mobile wallet stakes; while there are plenty of competitors in this field, being able to offer up not only mobile wallet services but also security for same should be a big help in the long term.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding TSA PreCheck's Impact on Travelers The latest survey reveals some interesting insights about TSA PreCheck, especially concerning the time savings that members experience at security checkpoints. Conducted by Upgraded Points, this enlightening study assessed the experience of over 1,500 travelers to evaluate the true advantages of holding a TSA PreCheck...
Continue Reading
Intermap Technologies Announces New Prospectus Supplement DENVER – Intermap Technologies Corporation (TSX: IMP; OTCQB: ITMSF), a recognized leader in 3D geospatial products and intelligence solutions, has filed a prospectus supplement in the context of a strategically planned public offering. This initiative signifies a promising step forward, with the company aiming to...
Continue Reading
Critical Deadline for Humacyte Investors Approaches As time runs short, investors in Humacyte, Inc. (NASDAQ: HUMA) should pay attention. Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating claims on behalf of investors who have suffered losses exceeding $75,000 due to potential violations in federal securities laws. Understanding Your...
Continue Reading
Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab Natalie Bartholomew, a highly recognized advocate for women in financial services, will be the featured speaker for the Women in Banking session at Alkami Co:lab 2026. Her expertise and passion are expected to inspire attendees and foster discussions around women's roles in the financial sector. Alkami...
Continue Reading
OPAL Fuels Earnings Report Insights OPAL Fuels OPAL is preparing to release its quarterly earnings report soon, and investors are keenly interested in the results. As the anticipated date for this report approaches, it is essential for investors to stay informed and understand what the expectations are. Projected Earnings Overview Analysts project that OPAL Fuels will...
Continue Reading